Camarillo, CA, United States of America

Mark D Dobbs

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Camarillo, CA (US) (2016 - 2020)
  • Brea, CA (US) (2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Mark D Dobbs

Introduction

Mark D Dobbs is a notable inventor based in Camarillo, California. He has made significant contributions to the field of biomedical engineering, particularly in the area of nucleic acid detection. With a total of five patents to his name, Dobbs has demonstrated a commitment to advancing medical technology.

Latest Patents

Among his latest patents is a groundbreaking method for processing blood samples to detect target nucleic acids. This innovation involves the use of porous polymer monolith materials and processes that enable the integration of blood fractionation, specific nucleic acid amplification, and detection of nucleic acids from whole blood. This technology has the potential to enhance diagnostic capabilities in medical settings.

Career Highlights

Throughout his career, Dobbs has worked with several prominent organizations. He has been associated with Monolythix, Inc. and the Alfred E. Mann Foundation for Scientific Research. His work in these institutions has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.

Collaborations

Some of his notable coworkers include Keith A Oberg and Milton Lee. Their collective expertise has fostered an environment of innovation and creativity, leading to the development of impactful technologies.

Conclusion

Mark D Dobbs is a distinguished inventor whose work in nucleic acid detection is paving the way for advancements in medical diagnostics. His contributions are invaluable to the field and continue to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…